CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications.

Int J Mol Sci · 2025 · PMC12428824 · PMID 40943530

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

used a self-produced CD93 monoclonal antibody (mNI-11) with three commercial antibodies (R139, R3, and X-2) to identify a novel cell population (CD4 + CD45RA + CD93 + ) in neonatal umbilical cord blood, which may be significant in cell biology, transplantation, and immune responses [ 29 ].

also in 7,550 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.